Overview
International law firm McDermott Will & Emery represented Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system disorders, in its acquisition of AlloMek Therapeutics, LLC, a privately held biotechnology company. The transaction closed on October 11, 2022.
The McDermott team was led by Robert Cohen and Eric Klee and included James Behrens, Mark Bilut, Cristell Fortune, Anisa Mohanty, Nick Paul, David Saunders, Michael Siekman, Jeronimo Soares de Sousa, Todd Solomon, Michelle Strowhiro, Kate Williams and Daniel Zucker.
Read Pasithea’s press release here.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
